EXPERIENCE WITH INTRAOPERATIVE CHEMOIMMUNOTHERAPY AFTER RADICAL OPERATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

The purpose of this study was to evaluate the tolerability and effects on the immune status of patients with radically resection of non-small cell lung cancer new method of intraoperative chemoimmunotherapy. Pilot results treatment of twenty patients indicate a satisfactory tolerability and positive impact on the immune status. Further study of the effectiveness of this method as a component of the complex treatment of early-stage nonsmall cell lung cancer seems to be promising.